Will FDA Ban Electrical Stimulation Devices?

Electrical stimulation devices used to treat aggressive or self-injurious behavior would be banned under a new rule proposed by the FDA due to the risks associated with the treatment.

The machines, which work by attaching electrodes to a person’s skin through which electric shocks are delivered, are intended to condition the body to cease from engaging in self-injurious or aggressive activities. However, the devices are associated with significant side effects, both physical and psychological in nature.

Anxiety, depression, symptoms of post-traumatic stress disorder and worsening of self-injurious behaviors have been associated with the devices. Burns, pain, tissue damage and errant shocks have also been reported. Also, many people that use the devices have developmental or intellectual disabilities that may make it difficult for them to express pain or their consent in using the machine.

Click for the full ProPublica story

The FDA saysthe devices need to be banned since the risks “cannot be eliminated through new or updated labeling.”

“These devices are dangerous and a risk to public health — and we believe they should not be used,” William Maisel, MD, MPH, acting director of the Office of Device Evaluation in the FDA’s Center for Devices and Radiological Health, said in a statement.

Currently, only one place is using the devices, the Judge Rotenberg Educational Center in Canton, MA. The FDA believes between 45 and 50 people are using it there.

More modern behavioral treatments are available instead of the devices that don’t carry such side effects, according to the agency. These include medications and behavioral support.

Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.

Did you find this article helpful?

Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement